Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a long non-coding RNA transcribed antisense to the RABEP1 gene. Antisense transcripts frequently modulate their corresponding sense gene by affecting chromatin marks, transcriptional dynamics, and mRNA stability[1]. However, for ENSG00000263220 specifically, no functional characterization, disease association, or drug targeting information is currently available in public biomedical databases or the literature. Its status as a "target" is ambiguous and likely incorrect; it is best classified as an annotated antisense RNA locus with unknown or inferred regulatory roles rather than a conventional drug target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to Rabaptin, RAB GTPase Binding Effector Protein 1.